Prognostic and predictive value of epidermal growth factor receptor in recurrent breast cancer

Clinical Cancer Research

Volumn 8, Issue 11, 2002, Pages 3454-3460

  Tsutsui, Shinichi ^a   Kataoka, Akemi ^b   Ohno, Shinji ^b   Murakami, Shigeru ^b   Kinoshita, Junko ^b   Hachitanda, Yoichi ^b  

^a NATIONAL HOSPITAL ORGANIZATION BEPPU MEDICAL CENTER   (Japan)

^b NATIONAL KYUSHU CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTIESTROGEN; AROMATASE INHIBITOR; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; FLUOROURACIL; GONADORELIN DERIVATIVE; MEDROXYPROGESTERONE ACETATE; METHOTREXATE; MITOMYCIN C; NAVELBINE; TAMOXIFEN; TAXANE DERIVATIVE; THIOTEPA; TOREMIFENE; VINCRISTINE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; HORMONAL THERAPY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; BIOSYNTHESIS; BREAST TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; RECURRENT DISEASE; TIME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECURRENCE; TIME FACTORS;

EID: 0036848757     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 Randomised trials involving 31, 000 recurrences and 24, 000 deaths among 75, 000 women. Lancet, 339: 1-15, 71-85, 1992
2. Tsutsui, S., Ohno, S., Murakami, S., Hachitanda, Y., and Oda, S. Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer. Breast Cancer Res. Treat., 71: 67-75, 2002
3. Clark, G. M., Sledge, G. W., Osborne, C. K., and MacGuire, W. L. Survival from first recurrence: Relative importance of prognostic factors in 1, 015 breast cancer patients. J. Clin. Oncol., 5: 55-61, 1987
4. Stewart, J. F., King, R. J. B., Sexton, S. A., Millis, R. R., Rubens, R. D., and Hayward, J. L. Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer. Eur. J. Cancer, 17: 449-453, 1981
5. Koenders, P. G., Beex, L. V. A. M., Kloppenborg, P. W. C., Smals, A. G. H., Benraad, T. J., and the Breast Cancer Study Group. Human breast cancer: Survival from first metastasis. Breast Cancer Res. Treat., 21: 173-180, 1992
6. Solomayer, E. F., Diel, I. J., Meyberg, G. C., Gollan, C., and Bastert, G. Metastatic breast cancer: Clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res. Treat., 59: 271-278, 2000
7. Downward, J., Parker, P., and Waterfield, M. D. Autophosphorylation sites on the epidermal growth factor receptor. Nature (Lond.), 311: 483-485, 1984
8. Nicholson, R. I., and Gee, J. M. W. Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer. Br. J. Cancer, 82: 501-513, 2001
9. Berthois, Y., Dong, X. F., and Martin, P. M. Regulation of epidermal growth factor receptor by oestrogen and antioestrogen in the human breast cancer cell line MCF-7. Biochem. Biophys. Res. Commun., 159: 126-131, 1989
10. Yarden, R. I., Lauber, A. H., El-Ashry, D., and Chrysogelos, S. A. Bimodal regulation of epidermal growth factor receptor by estrogen in breast cancer cells. Endocrinology, 137: 2739-2747, 1996
11. van Agthoven, T., van Agthoven, T. L. A., Portengen, H., Foekens, J. A., and Dorssers, L. C. J. Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75-1 human breast cancer cells. Cancer Res., 52: 5082-5088, 1992
12. Bunone, G., Briand, P., Miksicek, R. J., and Picard, D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J., 15: 2174-2183, 1996
13. Ignar-Trowbridge, D. M., Pimentel, M., Parker, M. G., McLachlan, J. A., and Korach, K. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology, 137: 1735-1744, 1996
14. Sainsbury, J. R., Farndorn, J. R., Needham, G. K., Malcolm, A. J., and Harris, A. L. Epidermal-growth-factor receptor status as a predictor of early recurrence of and death from breast cancer. Lancet, i: 1398-1402, 1987
15. Klijn, J. G. M., Berns, P. M. J. J., Schmitz, P. I. M., and Foekens, J. A. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: A review on 5232 patients. Endocr. Rev., 13: 156-170, 1992
16. Nicholson, S., Richard, J., Sainsbury, C., Halcrow, P., Kelly, P., Angus, B., and Wright, C. Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative group. Br. J. Cancer, 63: 146-150, 1991
17. Fox, S. B., Smith, K., Hollyer, J., Greenall, M., Hastrich, D., and Harris, A. L. The epidermal growth factor receptor as a prognostic marker: Results of 370 patients and review of 3009 patients. Breast Cancer Res. Treat., 29: 41-49, 1994
18. Sheshadri, R., Mcleay, W. R. B., Horsefall, D. J., and McCaul, K. Prospective study of the prognostic significance of epidermal growth factor receptor in primary breast cancer. Int. J. Cancer, 69: 23-27, 1996
19. Torregrosa, D., Bolufer, P., Lluch, A., Lopez, J. A., Barragan, E., Ruiz, A., Guillem, V., Munarriz, B., and Conde, J. G. Prognostic significance of c-erb-B2/neu amplification and epidermal growth factor receptor (EGFR) in primary breast cancer and their relation to estradiol receptor (ER) status. Clin. Chim. Acta, 262: 99-119, 1997
20. Nicholson, R. I., McClelland, R. A., Gee, J. M. W., Manning, D. L., Cannon, P., Robertson, J. F. R., Ellis, I. O., and Blamey, R. W. Epidermal growth factor receptor expression in breast cancer: Association with responses to endocrine therapy. Breast Cancer Res. Treat., 29: 117-125, 1994
21. Archer, S. G., Eliopoulos, A., Spandidos, D., Barnes, D., Ellis, I. O., Blamey, R. W., Nicholson, R. I., and Robertson, J. F. R. Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy. Br. J. Cancer, 72: 1259-1266, 1995
22. Tsutsui, S., Ohno, S., Murakami, S., Kataoka, A., Kinoshita, J., and Hachitanda, Y. Comparison of the immunohistochemical expression of EGFR, c-erbB2 and p53 protein between primary and recurrent breast cancer. Breast Cancer, 9: 111-117, 2002
23. Sharma, A. K., Horgan, K., Douglas-Jones, A., McClelland, R., Gee, J., and Nicholson, R. Dual immunocytochemical analysis of oestrogen and epidermal growth factor receptors in human breast cancer. Br. J. Cancer, 69: 1032-1037, 1994
24. Davidson, N. E., Gelman, E. P., Lippman, M. E., and Dickson, R. B. Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. Mol. Endocrinol., 1: 216-223, 1987
25. Nicholson, S., Sainsbury, J. R., Halcrow, P., Chambers, P., Farndon, J. R., and Harris, A. L. Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer. Lancet, i: 182-184, 1989
26. Harris, A. L., Nicholson, S., Sainsbury, J. R. C., Farndon, J., and Wright, C. Epidermal growth factor receptors in breast cancer: Association with early relapse and death, poor response to hormones and interaction with neu. J. Steroid Biochem., 34: 123-131, 1989
27. Nicholson, R. I., McClelland, R. A., Finlay, P., Eaton, C. L., Gullick, W. J., Dixon, A. R., Robertson, J. F. R., Ellis, I. O., and Blamey, R. W. Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivity. Eur. J. Cancer, 29A: 1018-1023, 1993
28. Cantwell, B. M. J., Hennessy, C., Millward, M. J., and Lennard, T. W. J. Epidermal growth factor receptors and doxorubicin plus ifosfamide/MESNA in recurrent breast cancer. Lancet, 337: 1417, 1991
29. Dickstein, B. M., Wosikowski, K., and Bates, S. E. Increased resistance to cytotoxic agents in ER75B human breast cancer cells transfected with epidermal growth factor receptor. Mol. Cell. Endocrinol., 110: 205-211, 1995
30. Mendelsohn, J., and Fan, Z. Epidermal growth factor receptor family and chemosensitization. J. Natl. Cancer Inst., 89: 341-343, 1997